Back to Search
Start Over
Plasma treated bimetallic nanofibers as sensitive SERS platform and deep learning model for detection and classification of antibiotics.
- Source :
-
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2025 Feb 15; Vol. 327, pp. 125417. Date of Electronic Publication: 2024 Nov 10. - Publication Year :
- 2025
-
Abstract
- Design of a sensitive, cost-effective SERS substrate is critical for probing analyte in trace concentration in real field environment. Present work reports the fabrication of an oxygen (O <subscript>2</subscript> ) plasma treated bimetallic nanofibers as a sensitive SERS platform. In contrast to the conventional nanofiber-based SERS platform, the proposed plasma-treated bimetallic nanofibers-based SERS platform offers high sensitivity and reproducibility characteristics. On top, the use of bimetallic nanoparticles provides a synergistic effect, contributing to both electromagnetic and chemical enhancement to SERS performance and the plasma treatment contributes to the controlled exposure of the embedded nanoparticles (NPs) to the analyte thereby enhancing the overall sensitivity of the proposed technique. With standard Raman active probe molecules - 1,2-bis(4-pyridyl) ethylene (BPE) and rhodamine-6G (R6G) the limit of detection (LOD) and the limit of quantification (LOQ) of the proposed sensing platform are estimated to be 3.8 nM and 11.6 nM respectively. The enhancement factor (EF) of the designed sensing platform is calculated to be ∼10 <superscript>8</superscript> with a maximum signal variations of 5 %. The applicability of the designed SERS substrate has been realized through detection of two antibiotics - fluconazole (FLU) and lincomycin (LIN) widely used in poultry farms. Furthermore, a deep learning model - artificial neural network (ANN) has been implemented for effective classification of the analyte molecules from a mixed sample.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1873-3557
- Volume :
- 327
- Database :
- MEDLINE
- Journal :
- Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
- Publication Type :
- Academic Journal
- Accession number :
- 39541643
- Full Text :
- https://doi.org/10.1016/j.saa.2024.125417